HIV Citations List: May, 2016

Literature Citations

1. Human DDX3 Protein Is a Valuable Target to Develop Broad Spectrum Antiviral Agents. Brai, A., R. Fazi, C. Tintori, C. Zamperini, F. Bugli, M. Sanguinetti, E. Stigliano, J. Este, R. Badia, S. Franco, M.A. Martinez, J.P. Martinez, A. Meyerhans, F. Saladini, M. Zazzi, A. Garbelli, G. Maga, and M. Botta. Proceedings of the National Academy of Sciences of the United States of America, 2016. 113(19): p. 5388-5393. PMID[27118832]. PMCID[PMC4868442].
[PubMed]. HIV_05_2016.

2. Pharmacology and Synthesis of Daurichromenic acid as a potent anti-HIV Agent. Bukhari, S.M., I. Ali, A. Zaidi, N. Iqbal, T. Noor, R. Mehmood, M.S. Chishti, B. Niaz, U. Rashid, and M. Atif. Acta Poloniae Pharmaceutica, 2015. 72(6): p. 1059-1071. ISI[000373862600001].
[WOS]. HIV_05_2016.

3. Anti-HIV-1 Integrase Compounds from Dioscorea bulbifera and Molecular Docking Study. Chaniad, P., C. Wattanapiromsakul, S. Pianwanit, and S. Tewtrakul. Pharmaceutical Biology, 2016. 54(6): p. 1077-1085. PMID[26864337].
[PubMed]. HIV_05_2016.

4. Development of Potent and Long-acting HIV-1 Fusion Inhibitors. Chong, H., X. Wu, Y. Su, and Y. He. AIDS, 2016. 30(8): p. 1187-1196. PMID[26919736].
[PubMed]. HIV_05_2016.

5. Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H. Kankanala, J., K.A. Kirby, F. Liu, L. Miller, E. Nagy, D.J. Wilson, M.A. Parniak, S.G. Sarafianos, and Z. Wang. Journal of Medicinal Chemistry, 2016. 59(10): p. 5051-5062. PMID[27094954]. PMCID[PMC4882222].
[PubMed]. HIV_05_2016.

6. The First Synthesis and Anti-retroviral Activity of 5,5-Difluoro-3-hydroxy-apiosyl Nucleoside Cyclomonophosphonic acid Analogs. Kim, S. and J.H. Hong. Bulletin of the Korean Chemical Society, 2016. 37(4): p. 425-433. ISI[000374009600002].
[WOS]. HIV_05_2016.

7. Expedient Screening for HIV-1 Protease Inhibitors Using a Simplified Immunochromatographic Assay. Kitidee, K., W. Khamaikawin, W. Thongkum, Y. Tawon, T.R. Cressey, R. Jevprasesphant, W. Kasinrerk, and C. Tayapiwatana. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 2016. 1021: p. 153-158. PMID[26490422].
[PubMed]. HIV_05_2016.

8. Substituted Indoles as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: A Patent Evaluation (WO2015044928). Li, X., P. Gao, P. Zhan, and X.Y. Liu. Expert Opinion on Therapeutic Patents, 2016. 26(5): p. 629-635. PMID[26742549].
[PubMed]. HIV_05_2016.

9. Synthesis and anti-HIV-1 Evaluation of Some Novel MC-1220 Analogs as Non-Nucleoside Reverse Transcriptase Inhibitors. Loksha, Y.M., E.B. Pedersen, R. Loddo, and P. La Colla. Archiv der Pharmazie, 2016. 349(5): p. 363-372. PMID[26996241].
[PubMed]. HIV_05_2016.

10. HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Incorporation of Benzylphosphonate Moiety for Solubility Improvement. Matyugina, E.S., V.T. Valuev-Elliston, A.O. Chizhov, S.N. Kochetkov, and A.L. Khandazhinskaya. Mendeleev Communications, 2016. 26(2): p. 114-116. ISI[000374813300009].
[WOS]. HIV_05_2016.

11. Design, Synthesis and Evaluation of Novel HIV-1 NNRTIs with Dual Structural Conformations Targeting the Entrance Channel of the NNRTI Binding Pocket. Meng, Q., X.W. Chen, D.W. Kang, B.S. Huang, W.X. Li, P. Zhan, D. Daelemans, E. De Clercq, C. Pannecouque, and X.Y. Liu. European Journal of Medicinal Chemistry, 2016. 115: p. 53-62. PMID[26994843].

[PubMed]. HIV_05_2016.

12. Small-molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors. Ohashi, N., S. Harada, T. Mizuguchi, Y. Irahara, Y. Yamada, M. Kotani, W. Nomura, S. Matsushita, K. Yoshimura, and H. Tamamura. ChemMedChem, 2016. 11(8): p. 940-946. PMID[26891461].
[PubMed]. HIV_05_2016.

13. Bioavailable Inhibitors of HIV-1 RNA Biogenesis Identified through a Rev-based Screen. Prado, S., M. Beltran, M. Coiras, L.M. Bedoya, J. Alcami, and J. Gallego. Biochemical Pharmacology, 2016. 107: p. 14-28. PMID[26896646].
[PubMed]. HIV_05_2016.

14. Synergistic Reduction of HIV-1 Infectivity by 5-Azacytidine and Inhibitors of Ribonucleotide Reductase. Rawson, J.M.O., M.E. Roth, J.S. Xie, M.B. Daly, C.L. Clouser, S.R. Landman, C.S. Reilly, L. Bonnac, B. Kim, S.E. Patterson, and L.M. Mansky. Bioorganic & Medicinal Chemistry, 2016. 24(11): p. 2410-2422. PMID[27117260].
[PubMed]. HIV_05_2016.

15. Drug Interaction Profile of the HIV Integrase Inhibitor Cabotegravir: Assessment from in Vitro Studies and a Clinical Investigation with Midazolam. Reese, M.J., G.D. Bowers, J.E. Humphreys, E.P. Gould, S.L. Ford, L.O. Webster, and J.W. Polli. Xenobiotica, 2016. 46(5): p. 445-456. PMID[26340566].
[PubMed]. HIV_05_2016.

16. Dimerization Inhibition of HIV-1 RNA by 2'-Deoxy-2'-fluoro-beta-D-arabinose Nucleic acid (2'-FANA) Modified Antisense Oligonucleotides Results in Potential Inhibition of Viral Expression. Takahashi, M., H.T. Li, V. Aishwarya, M.J. Damha, and J.J. Rossi. Molecular Therapy, 2016. 24: p. S232-S233. ISI[000375264200577].
[WOS]. HIV_05_2016.

17. Discovery of Non-peptide Small Molecular CXCR4 Antagonists as anti-HIV Agents: Recent Advances and Future Opportunities. Zhang, H., D. Kang, B. Huang, N. Liu, F. Zhao, P. Zhan, and X. Liu. European Journal of Medicinal Chemistry, 2016. 114: p. 65-78. PMID[26974376].
[PubMed]. HIV_05_2016.

18. Purification and Characterization of a White Laccase with Pronounced Dye Decolorizing Ability and HIV-1 Reverse Transcriptase Inhibitory Activity from Lepista nuda. Zhu, M.J., G.Q. Zhang, L. Meng, H.X. Wang, K.X. Gao, and T. Ng. Molecules, 2016. 21(4):E415. PMID[27023513].
[PubMed]. HIV_05_2016.

Patent Citations

19. Conjugated Molecules Comprising a Peptide Derived from the CD4 Receptor Coupled to an Anionic Polypeptide for the Treatment of AIDS. Baleux, F., H. Lortat-Jacob, D. Bonnaffe, and Y.-M. Coiec. Patent. 2016. 2015-EP74598 2016062854: 53pp.

[Patent]. HIV_05_2016.

20. Preparation of Triaminotriazine picolinonitrile Derivatives for Treatment of Hyperproliferative Disease and HIV-1 Infection. Mane, D.V., S.N. Gavade, S.S. Kulkarni, and R.S. Paranjape. Patent. 2016. 2015-IN386 2016059647: 34pp.

[Patent]. HIV_05_2016.

21. Alkaloids from Sponge, Scaffolds for the Inhibition of Human Immunodeficiency Virus (HIV) Infection. O'Rourke, A., S. Kremb, and C.R. Voolstra. Patent. 2016. 2015-IB2126 2016067090: 50pp.

[Patent]. HIV_05_2016.

22. Histone Deacetylase Inhibitor Reactivation of Latent Human Immunodeficiency Virus. Pantaleo, G. and M. Perreau. Patent. 2016. 2015-IB58168 2016063251: 40pp.

[Patent]. HIV_05_2016.

23. Boronic acid Inhibitors of HIV Protease. Raines, R.T., I. Windsor, M. Palte, and J. Lukesh. Patent. 2016. 2015-14927390 20160122366: 54pp.

[Patent]. HIV_05_2016.

24. Preparation of C17-Aryl Substituted Betulinic acid Analogs. Sin, N., Y. Chen, S.-Y. Sit, J. Chen, A. Regueiro-Ren, and N.A. Meanwell. Patent. 2016. 2015-US60353 2016077569: 79pp.

[Patent]. HIV_05_2016.

25. Preparation of Extended Betulinic acid Analogs as HIV Maturation Inhibitors. Sit, S.-Y., J. Chen, Y. Chen, J. Swidorski, A. Regueiro-Ren, and N.A. Meanwell. Patent. 2016. 2015-US60360 2016077572: 109pp.

[Patent]. HIV_05_2016.